Study analyses novel strategies to tackle allergic reactions
Updated:5 years, 5 months ago
Updated:5 years, 5 months ago
New Delhi, May 22 (ANI): Allergic reactions have been a matter of concern for a long time and nearly one-third of the world's population suffers from allergies. However, the results obtained from a new study may help improve the diagnosis and treatment of allergies, pointing to a potential marker of these conditions and a new therapeutic strategy. The study led by investigators at Massachusetts General Hospital and the results was published in Nature. Certain antibodies--called IgE antibodies--bind to allergens such as peanuts and trigger a reaction that releases an array of molecules that cause allergic symptoms, and in extreme cases, potentially life-threatening anaphylaxis. Scientists have been perplexed by the fact that many individuals have circulating allergen-specific IgE antibodies without ever developing allergy symptoms. For example, about half of the people who have peanut-specific IgE antibodies (or test positive to a peanut skin prick test) do not have peanut allergies. In addition, some allergic individuals outgrow their symptoms yet still retain detectable levels of circulating allergen-specific IgE.
Updated:4 years, 9 months ago
Pan-India dry run for COVID vaccine tomorrow: Harsh Vardhan
Updated:4 years, 9 months ago
PM Modi joins world leaders in condemning US Capitol siege
Updated:4 years, 10 months ago
Indo-Japan Samvad: Buddha’s message spread out from India to world, says PM Modi
Updated:4 years, 10 months ago
Centre preparing with states for past 4 months for COVID-19 vaccination: Harsh Vardhan
Updated:4 years, 10 months ago
In Jan, India may be in position to give 1st COVID vaccine shot: Harsh Vardhan
Updated:4 years, 10 months ago
Worst is over but still need to be cautious: Health Minister on COVID-19 cases in India